US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Veraxa Biotech Holding AG

1.64

+0.04502.83%

Volume:363.15K

Turnover:591.62K

Market Cap:231.20M

PE:7.63

High:1.68

Open:1.59

Low:1.57

Close:1.59

52wk High:27.36

52wk Low:1.27

Shares:141.41M

Float Shares:82.20M

Volume Ratio:0.50

T/O Rate:0.44%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.2142

EPS(LYR):-5.8037

ROE:-871.42%

ROA:-49.99%

PB:-11.92

PE(LYR):-0.28

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Veraxa Biotech Names Raju Willener as CFO

Veraxa Biotech Appoints Raju Willener as Chief Financial Officer

THOMSON REUTERS

Veraxa Biotech CEO Christoph Antz Reports Purchase of 5,000 Shares for $7,650

VERAXA Biotech (NASDAQ: VRXA) Advances VXA-222 Cancer Program Beyond Discovery Phase

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/stock/VRXA"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"VRXA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VRXA\",,,,,undefined,":{"symbol":"VRXA","market":"US","secType":"STK","nameCN":"Veraxa Biotech Holding AG","latestPrice":1.635,"timestamp":1789064027897,"preClose":1.59,"halted":0,"volume":363145,"delay":0,"changeRate":0.028301886792452786,"floatShares":82198500,"shares":141407813,"eps":0.2142,"marketStatus":"Trading","change":0.045,"latestTime":"09-10 14:16:44 EDT","open":1.585,"high":1.68,"low":1.57,"amount":591622.5792075,"amplitude":0.069182,"askPrice":1.65,"askSize":118,"bidPrice":1.63,"bidSize":196,"shortable":3,"etf":0,"ttmEps":0.2142,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789070400000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":1.59,"preHourTrading":{"tag":"盘前","latestPrice":1.5606,"preClose":1.59,"latestTime":"09:29 EDT","volume":116600,"amount":181936.41356,"timestamp":1789046962523,"change":-0.0294,"changeRate":-0.018491,"amplitude":0.050314},"postHourTrading":{"tag":"盘后","latestPrice":1.5902,"preClose":1.59,"latestTime":"19:41 EDT","volume":711,"amount":1130.6708,"timestamp":1788997276491,"change":0.0002,"changeRate":0.000126,"amplitude":0.000126},"volumeRatio":0.495686},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VRXA\",,,,,undefined,":{"symbol":"VRXA","floatShares":82198500,"roa":"-49.99%","roe":"-871.42%","lyrEps":-5.803658,"volumeRatio":0.495686,"shares":141407813,"dividePrice":0,"high":1.68,"amplitude":0.069182,"preClose":1.59,"low":1.57,"week52Low":1.27,"pbRate":"-11.92","psRate":"8021.78","week52High":27.36,"institutionHeld":0,"latestPrice":1.635,"committee":0.248408,"eps":0.2142,"divideRate":0,"volume":363145,"delay":0,"ttmEps":0.2142,"open":1.585,"prevYearClose":18.65,"prevWeekClose":1.76,"prevMonthClose":1.35,"prevQuarterClose":1.88,"fiveDayClose":1.38,"twentyDayClose":1.89,"sixtyDayClose":21.26},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VRXA\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VRXA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VRXA\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/VRXA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"VRXA","date":"2026-09-09","current":7.633053,"percent":0.076923,"low":-3.022108,"twenty":-2.468126,"median":-1.306481,"eighty":-0.794674,"high":-0.413162,"avg":-1.489707,"sd":0.840052,"marketCap":226252500},"quantilePoints":[{"date":"2026-08-21","current":-1.35335,"twenty":-1.349054,"median":-1.34261,"eighty":-1.336165,"marketCap":47660725},{"date":"2026-08-28","current":-1.03732,"twenty":-1.349054,"median":-1.281094,"eighty":-1.194963,"marketCap":36312933},{"date":"2026-09-04","current":-2.622384,"twenty":-1.391748,"median":-1.265172,"eighty":-0.552029,"marketCap":216353953},{"date":"2026-09-09","current":-2.751957,"twenty":-2.468126,"median":-1.306481,"eighty":-0.794674,"marketCap":226252500}],"updateTime":1789064204160},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VRXA\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664336297","title":"Veraxa Biotech Names Raju Willener as CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2664336297","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664336297?lang=en_us&edition=fundamental","pubTime":"2026-09-04 19:00","pubTimestamp":1788519621,"startTime":"0","endTime":"0","summary":"Veraxa Biotech names Raju Willener as CFOVeraxa Biotech appointed Raju Willener as chief financial officer, effective immediately, reporting to CEO Christoph Antz.Willener previously served as directo","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nNDL15nJ5k:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","SG9999014005.SGD","LU2095319765.USD","VRXA","IE00BQXX3D17.EUR","IE00BQXX3C00.GBP","IE00B64PRP62.GBP","IE00BGHQF748.EUR","NDAQ","IE00BKPKM429.USD","IE00BN0W2V16.EUR","BK4588","LU2210150020.SGD","SG9999014039.USD","BK4585","IE00BN0W2W23.USD","IE00BQXX3F31.USD","LU0314104364.USD","IE00B3QW5Z07.USD","SG9999014013.SGD","IE00BN0W2T93.GBP","SG9999014021.USD","LU2210149790.SGD","BCDF","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664238336","title":"Veraxa Biotech Appoints Raju Willener as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2664238336","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664238336?lang=en_us&edition=fundamental","pubTime":"2026-09-04 19:00","pubTimestamp":1788519600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nTUA6WQX6T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","VRXA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664888755","title":"Veraxa Biotech CEO Christoph Antz Reports Purchase of 5,000 Shares for $7,650","url":"https://stock-news.laohu8.com/highlight/detail?id=2664888755","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664888755?lang=en_us&edition=fundamental","pubTime":"2026-09-01 04:10","pubTimestamp":1788207055,"startTime":"0","endTime":"0","summary":"Veraxa Biotech CEO Christoph Antz reports purchase of 5,000 shares for $7,650Veraxa Biotech CEO, director Christoph Rudiger Antz reported a purchase of 5,000 ordinary shares.The shares were bought at ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDL5ghMkz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Veraxa Biotech CEO Christoph Antz Reports Purchase of 5,000 Shares for $7,650","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VRXA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662530737","title":"VERAXA Biotech (NASDAQ: VRXA) Advances VXA-222 Cancer Program Beyond Discovery Phase","url":"https://stock-news.laohu8.com/highlight/detail?id=2662530737","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662530737?lang=en_us&edition=fundamental","pubTime":"2026-08-25 23:00","pubTimestamp":1787670008,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, August 25th, 2026, FinanceWire Following completion of the initial phase of its collaboration with OmniAb, VERAXA wil...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/veraxa-biotech-nasdaq-vrxa-advances-vxa-222-cancer-program-beyond-discovery-phase?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/veraxa-biotech-nasdaq-vrxa-advances-vxa-222-cancer-program-beyond-discovery-phase?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QLD","IYW","GPIQ","BK4581","QQQ","MNQmain","QQQM",".IXIC","BK4139","XBI","BK4585","BK4588","TECS","SQQQ","QQQE","QDTE","TQQY","QID","FTEC","VRXA","PSQ","JEPQ","NDX","TQQQ","ONEQ","QQQJ","QQQA","QQQY","QYLG","NQmain","NVIW.SI"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":18,"pageCount":1,"totalSize":71,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/VRXA\",params:#limit:6,delay:false,,,undefined,":[]}}